Our Funded Research
Since 2009, we have invested more than $2 million in multi-year commitments to targeted rare cancer research initiatives.
While TargetCancer Foundation does not focus on any one specific rare cancer — we tackle common challenges shared across all rare cancers — we are proud to support certain rare cancer-specific research efforts as part of our larger research portfolio.
Cholangiocarcinoma Research
One of our founding goals was to change the research landscape for cholangiocarcinoma. We have done this through a long-term commitment to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center, the establishment of a Cholangiocarcinoma Cell Line Bank, and targeted investments in driver mutation research.
Esophageal Cancer Research
Through targeted research grants and scientific meetings, we have worked to improve the understanding and treatment of esophageal cancer.
